Glucagon and insulin dual-hormone systems, without meal announcements (72) or with simple meal announcements (73), have been found to reduce both hyperglycaemia and hypoglycaemia compared to conventional insulin pump therapy. The gene discussed is INS; the disease is Hypoglycemia.